Estonia vs Japan: Cause of death, by non-communicable diseases, ages 5-14, female
Estonia
61.7%
in 2021
Japan
62.9%
in 2021
Estonia rank
32nd
Japan rank
30th
Cause of death, by non-communicable diseases, ages 5-14, female over time
- Estonia
- Japan
How they compare
Japan currently reports 62.9% against 61.7% in Estonia, a difference of 1.2%.
The two have swapped places 2 times across 6 shared years of data; in 2000 it was Japan ahead.
Estonia ranks 32nd and Japan ranks 30th of 184 countries.
Japan has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Estonia | Japan | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 42.2% | 57.4% | 15.2% | Japan |
| 2010s | 51.3% | 63.7% | 12.4% | Japan |
| 2020s | 51.5% | 61.2% | 9.7% | Japan |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 5-14, female, Estonia or Japan?
- Japan, at 62.9% against 61.7% in Estonia as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 5-14, female between Estonia and Japan?
- 1.2%, with Japan ahead.
- How many years of comparable data are there for Estonia and Japan?
- 6 years are reported by both, from 2000 to 2021.
- How do Estonia and Japan rank globally for cause of death, by non-communicable diseases, ages 5-14, female?
- Estonia ranks 32nd and Japan ranks 30th of 184 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 5-14, female (% of total female deaths ages 5-14). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of female deaths ages 5-14 due to non-communicable diseases divided by number of all female deaths ages 5-14, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.